Apellis Pharmaceuticals, Inc.
APLS
$17.97
$0.080.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.59% | 28.14% | 3.44% | -12.93% | 3.08% |
| Total Receivables | 4.10% | 54.71% | -6.20% | -10.06% | -4.31% |
| Inventory | 16.94% | 2.10% | 29.21% | 13.76% | -36.21% |
| Prepaid Expenses | -8.81% | -22.53% | -16.52% | 69.70% | 5.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.44% | 27.77% | 53.02% | 21.30% | 14.42% |
| Total Current Assets | 2.44% | 31.11% | 3.83% | -7.76% | -5.39% |
|
|
|||||
| Total Current Assets | 2.44% | 31.11% | 3.83% | -7.76% | -5.39% |
| Net Property, Plant & Equipment | -8.06% | 29.20% | -5.69% | -6.67% | -6.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.69% | -5.36% | -20.67% | -19.80% | 62.13% |
| Total Assets | 1.56% | 28.89% | 1.75% | -8.79% | -1.86% |
|
|
|||||
| Total Accounts Payable | 47.14% | -28.83% | -1.89% | 43.33% | -9.73% |
| Total Accrued Expenses | 18.33% | 0.95% | 19.68% | -17.15% | 0.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.15% | 1,256.02% | 6.84% | 2.83% | -0.57% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.77% | 39.30% | 12.49% | -3.84% | -3.01% |
|
|
|||||
| Total Current Liabilities | 15.77% | 39.30% | 12.49% | -3.84% | -3.01% |
| Long-Term Debt | 0.16% | -20.47% | 0.14% | 0.13% | 0.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.67% | 64.56% | -9.50% | -9.95% | -10.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 142.65% | 56.74% | -0.29% | -73.86% | -18.89% |
| Total Liabilities | 7.23% | -1.13% | 3.42% | -2.05% | -1.24% |
|
|
|||||
| Common Stock & APIC | 0.82% | 0.87% | 1.02% | 0.85% | 0.86% |
| Retained Earnings | -2.00% | 6.81% | -1.35% | -3.04% | -1.21% |
| Treasury Stock & Other | 12.38% | 6.58% | 15.88% | 7.68% | -5.35% |
| Total Common Equity | -7.73% | 156.66% | -4.82% | -28.15% | -3.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.73% | 156.66% | -4.82% | -28.15% | -3.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.73% | 156.66% | -4.82% | -28.15% | -3.62% |
|
|
|||||